News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
532,399 Results
Type
Article (37262)
Company Profile (112)
Press Release (495009)
Multimedia
Podcasts (139)
Webinars (28)
Section
Business (155385)
Career Advice (2893)
Deals (25306)
Drug Delivery (137)
Drug Development (64148)
Employer Resources (181)
FDA (13375)
Job Trends (10967)
News (242819)
Policy (24182)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2296)
Accelerated approval (53)
ADA (35)
Adcomms (26)
Allergies (171)
Alliances (36286)
ALS (196)
Alzheimer's disease (1591)
Antibody-drug conjugate (ADC) (484)
Approvals (13899)
Artificial intelligence (718)
ASCO (246)
Autoimmune disease (315)
Automation (56)
Bankruptcy (221)
Best Places to Work (9045)
BIO (62)
Biologics (2)
BIOSECURE Act (18)
Biosimilars (236)
BioSpace Insights (143)
Biotechnology (75)
Bladder cancer (198)
Brain cancer (68)
Breast cancer (679)
Cancer (5474)
Cardiovascular disease (419)
Career advice (2468)
Career pathing (57)
CAR-T (284)
CDC (38)
Celiac Disease (2)
Cell therapy (789)
Cervical cancer (49)
Clinical research (56973)
Collaboration (1967)
Commercialization (8)
Company closure (2)
Compensation (1105)
Complete response letters (87)
COVID-19 (2369)
CRISPR (106)
C-suite (952)
Cystic fibrosis (146)
Data (7680)
Decentralized trials (2)
Denatured (33)
Depression (177)
Dermatology (94)
Diabetes (547)
Diagnostics (5682)
Digital health (59)
Diversity (12)
Diversity, equity & inclusion (41)
Drug discovery (334)
Drug pricing (165)
Drug shortages (23)
Duchenne muscular dystrophy (255)
Earnings (62026)
Editorial (73)
Employer branding (23)
Employer resources (157)
Events (84194)
Executive appointments (836)
FDA (16994)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (18)
Frontotemporal dementia (32)
Funding (1483)
Gene editing (212)
Generative AI (59)
Gene therapy (634)
GLP-1 (955)
Government (4304)
Grass and pollen (8)
Guidances (388)
Healthcare (14294)
Hematology (156)
HIV (82)
Huntington's disease (44)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (103)
Immunology and inflammation (239)
Immuno-oncology (82)
Indications (212)
Infectious disease (2684)
Inflammatory bowel disease (200)
Inflation Reduction Act (10)
Influenza (120)
Intellectual property (264)
Interviews (567)
IPO (12725)
IRA (41)
Job creations (2155)
Job search strategy (1984)
JPM (62)
Kidney cancer (24)
Labor market (114)
Layoffs (350)
Leadership (55)
Legal (4245)
Licensing (10)
Liver cancer (85)
Longevity (31)
Lung cancer (760)
Lymphoma (426)
Machine learning (59)
Management (64)
Manufacturing (984)
Marketing (14)
MASH (197)
Medical affairs (1)
Medical device (9809)
Medtech (9965)
Mergers & acquisitions (13741)
Metabolic disorders (1401)
mRNA (212)
Multiple sclerosis (193)
NASH (20)
Neurodegenerative disease (401)
Neuropsychiatric disorders (102)
Neuroscience (3074)
Neurotech (1)
NextGen: Class of 2026 (5010)
Non-profit (3651)
Now hiring (74)
Obesity (604)
Opinion (337)
Ovarian cancer (194)
Pain (222)
Pancreatic cancer (278)
Parkinson's disease (340)
Partnered (34)
Patents (514)
Patient recruitment (716)
Peanut (55)
People (37018)
Pharmaceutical (38)
Pharmacy benefit managers (26)
Phase 1 (17036)
Phase 2 (25199)
Phase 3 (19492)
Pipeline (9521)
Policy (285)
Postmarket research (1796)
Preclinical (7162)
Press Release (44)
Prostate cancer (293)
Psychedelics (56)
Radiopharmaceuticals (284)
Rare diseases (1114)
Real estate (3564)
Recruiting (77)
Regulatory (20875)
Reports (61)
Research institute (2037)
Resumes & cover letters (469)
Rett syndrome (25)
RNA editing (18)
RSV (73)
Schizophrenia (175)
Series A (255)
Series B (183)
Service/supplier (6)
Sickle cell disease (112)
Special edition (30)
Spinal muscular atrophy (141)
Sponsored (46)
Startups (2620)
State (1)
Stomach cancer (14)
Supply chain (105)
Tariffs (71)
The Weekly (103)
Vaccines (981)
Venture capital (120)
Weight loss (391)
Women's health (122)
Worklife (26)
Date
Today (18)
Last 7 days (327)
Last 30 days (2059)
Last 365 days (24449)
2026 (15989)
2025 (24228)
2024 (28386)
2023 (32916)
2022 (42461)
2021 (45759)
2020 (44290)
2019 (36517)
2018 (27664)
2017 (25278)
2016 (23886)
2015 (28266)
2014 (20846)
2013 (16665)
2012 (17227)
2011 (17672)
2010 (15429)
Location
Africa (749)
Alabama (72)
Alaska (6)
Arizona (223)
Arkansas (10)
Asia (38211)
Australia (6219)
California (11593)
Canada (3688)
China (1496)
Colorado (503)
Connecticut (515)
Delaware (407)
Europe (73619)
Florida (1665)
Georgia (373)
Hawaii (4)
Idaho (41)
Illinois (913)
India (99)
Indiana (543)
Iowa (24)
Japan (583)
Kansas (114)
Kentucky (37)
Louisiana (48)
Maine (90)
Maryland (1479)
Massachusetts (8125)
Michigan (315)
Minnesota (574)
Mississippi (4)
Missouri (137)
Montana (25)
Nebraska (18)
Nevada (113)
New Hampshire (65)
New Jersey (3335)
New Mexico (26)
New York (3152)
North Carolina (1417)
North Dakota (7)
Northern California (5986)
Ohio (353)
Oklahoma (19)
Oregon (37)
Pennsylvania (2143)
Puerto Rico (20)
Rhode Island (31)
South America (941)
South Carolina (68)
Southern California (4623)
Tennessee (153)
Texas (1845)
United States (40800)
Utah (370)
Vermont (2)
Virginia (327)
Washington D.C. (50)
Washington State (888)
West Virginia (3)
Wisconsin (108)
Wyoming (1)
532,399 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
August 17, 2026
·
6 min read
Press Releases
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
August 12, 2026
·
6 min read
Press Releases
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
August 3, 2026
·
8 min read
Press Releases
Can-Fite Secures Japanese Patent Allowance for Namodenoson’s Anti-Obesity Technology
June 26, 2026
·
7 min read
Press Releases
Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer
July 14, 2026
·
5 min read
Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson
June 22, 2026
·
5 min read
Press Releases
Can-Fite to Present Late-Stage Clinical Pipeline and Licensing Opportunities at BIO International Convention 2026
June 17, 2026
·
6 min read
Press Releases
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World’s Premier Scientific Meetings in Oncology
July 20, 2026
·
7 min read
Press Releases
Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease
July 1, 2026
·
7 min read
Press Releases
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
March 4, 2026
·
5 min read
1 of 53,240
Next
